Medcan Australia
PrivateLast Round
Early Funding
Jan 10, 2022
Total Funding Raised
$8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Medcan Australia is a pharmaceutical and biotechnology company that cultivates, produces, and manufactures medicinal cannabis products for clinical and individual patient use.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain, Compliance, Quality Management
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Medcan Australia Comparables
Compare Medcan Australia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Australian Natural Therapeutics Group | 89% | |
| Cymra Life Sciences | 86% | |
| Cann Group Ltd | 86% | |
Medcan Australia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jan 10, 2022 | ||||
| Seed | Nov 1, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 25, 2026
Grew 17% QoQ, from 29 to 34 employees.
- May 17, 2026
Monthly visitors grew 69% MoM, reaching 2.3K.
Medcan Australia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Medcan Australia's valuation, stock price, and market status.